IRCT201202251556N35
Completed
Phase 2
The effect of intranasal oxytocin on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- schizophrenia.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18\-50, Diagnosis of Schizophrenia based on DSM IV 3 chronic Schizophrenia( duration of the disorder\>2 years), Minimum Score of 60 on Positive and Negative Scale
Exclusion Criteria
- •1\- Substance dependence,2\- IQ \<70, 3\-any other mental disorder on axis I, 4\-Any serious medical or neurological problem ,5\- receiving ECT during the last 14 days, 6\- hepatic disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Effects of intranasal application of oxytocin on empathy and mentalising in patients with psychotic disorders and severe personality disordersEUCTR2007-006561-32-DEWL University Hospital Bochum
Active, not recruiting
Phase 1
Oxytocin intranasal administrations in children with Prader-Willi syndrome aged from 3 to 12 years.EUCTR2016-003273-18-FRniversity Hospital of Toulouse40
Not yet recruiting
Phase 2
Oxytocin & benzodiazepines2024-516262-11-00St. Olavs Hospital HF60
Suspended
Phase 3
The effects of intranasal oxytocin on emotion processing and carer burden in individuals diagnosed with frontotemporal dementiaFrontotemporal DementiaEmotion ProcessingNeurological - DementiasACTRN12618001807246The University of Sydney40
Completed
Phase 3
Evaluation of Intranasal oxytocine spray effect on preventing post-dural puncture headache after cesarean sectiopost-dural puncture headache.Spinal and epidural anesthesia-induced headache during the puerperiumO89.4IRCT20201215049725N1Karaj University of Medical Sciences170